Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caveolin-3 is a membrane-associated scaffolding protein and the principal structural component of caveolae (small invaginations in the plasma membrane) specific to muscle tissue, particularly cardiac and skeletal muscle[1][3][4]. It is encoded by the CAV3 gene and is 151 amino acids in length. Caveolin-3 organizes and supports various signaling complexes, regulates ion channels (such as sodium channels critical for cardiac rhythm), and maintains sarcolemmal stability and muscle cell homeostasis. Mutations in CAV3 disrupt caveolae formation and have been linked to a spectrum of muscle diseases, including limb-girdle muscular dystrophy type 1C, distal myopathy, rippling muscle disease, hyperCKemia, and various cardiomyopathies[2][3][4]. Caveolin-3 also plays a role in signaling pathways relevant to cellular protection and stress response in cardiac muscle[1].
Stabilization/restoration of caveolae structure; Regulation of associated signaling pathways (PI3K/Akt/eNOS/PKC); Modulation of sarcolemmal membrane stability
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caveolin-3 (Cav-3).